Autor(es)

Miguel, Tarciso Tadeu ^[1] ; Games, Karina Santos ^[1] ; Nunes-de-Souza, Ricardo Luiz ^[1]

Afiliação do(s) autor(es)

^[1] UNESP, Fac Ciencias Farmaceut, Farmacol Lab, BR-14801902 Araraquara, SP - Brazil

• Tipo de documento: Artigo Científico
• Fonte: Hormones and Behavior; v. 66, n. 2, p. 247-256, JUL 2014.
• Citações Web of Science: 16

Resumo

The medial prefrontal cortex (mPFC) and the neuropeptide corticotropin-releasing factor (CRF) have recently been receiving more attention from those interested in the neurobiology of anxiety. Here, we investigated the CRF pathway in the modulation of anxiety-like behaviors in male mice exposed to the elevated plus-maze (EPM), through intra-mPFC injections of CRF, CP376395 {[}N-(1-ethylpropyl)-3,6-dimethyl-2-(2,4,6-trimethylphenoxy)-4-pyridinam ine hydrochloride, a CRF type 1 receptor antagonist (CR F1)] or H-89 {[}N-{[}2-{[}{[}3-(4-bromophenyl)-2-propenyl]amino]ethy11-5 Aso quinolinesulf onamide dihydrochloride, a protein kinase (PICA) inhibitor]. We also investigated the effects of intra-mPFC injections of H-89 on the behavioral effects induced by CRF. Mice received bilateral intra-mPFC injections of CRF (0, 37.5, 75 or 150 pmol), CP376395 (0, 0.75, 1.5 or 3 nmol) or H-89 (0, 1.25, 2.5 or 5 nmol) and were exposed to the EPM, to record conventional and complementary measures of anxiety for 5 mm. Results showed that while CRF (75 and 150 pmol) produced an anxiogenic-like effect, CP376395 (all doses) and H-89 (5 nmol) attenuated anxiety-like behavior. When injected before CRF (150 pmol), intra-mPFC H-89 (2.5 nmol, a dose devoid of intrinsic effects on anxiety) completely blocked the anxiogenic-like effects of CRF. These results suggest that (i) CRF plays a tonic anxiogenic-like role at CRF1 receptors within the mPFC, since their blockade per se attenuated anxiety indices and (ii) the anxiogenic-like effects following CRF1 receptor activation depend on CAMP/PICA cascade activation in this limbic forebrain area. (C) 2014 Elsevier Inc All rights reserved. (AU)

• Processo FAPESP: 10/01290-4 - Papel do fator de liberação de corticotrofina (CRF) e do complexo NMDA-Óxido Nítrico-GMPc na neurobiologia das reações de defesa em camundongos: uma abordagem farmacológica, molecular e etoexperimental
• Beneficiário: Karina Santos Gomes
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado
• Processo FAPESP: 13/01283-6 - Sistema hierárquico de defesa no camundongo: modulação pelo fator de liberação de corticotrofina (CRF)
• Beneficiário: Ricardo Luiz Nunes de Souza
• Modalidade de apoio: Auxílio à Pesquisa - Regular